licaminlimab (OCS-02) - Oculis
RELIEF: Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease (clinicaltrials.gov) - Jan 23, 2025 - P2 | N=122 | Completed | Sponsor: Oculis | Active, not recruiting ➔ Completed | Trial completion date: Dec 2024 ➔ Mar 2024 
Trial completion • Trial completion date • Dry Eye Disease • Ophthalmology
http://clinicaltrials.gov/ct2/show/NCT05896670
 
Jan 23, 2025
 
Prev Next